Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Vaccines

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 49 articles: HTML format Text format

Single Articles

May 2019
1. WANG S, Qin L, Yamankurt G, Skakuj K, et al
   Rational vaccinology with spherical nucleic acids.
   Proc Natl Acad Sci U S A. 2019 May 8. pii: 1902805116.
   PubMed     Text format     Abstract available
   
   
   April 2019
2. WELLS CR, Pandey A, Parpia AS, Fitzpatrick MC, et al
   Ebola vaccination in the Democratic Republic of the Congo.
   Proc Natl Acad Sci U S A. 2019 Apr 29. pii: 1817329116.
   PubMed     Text format     Abstract available
   
   
   
3. WEIDENBACHER PA, Kim PS
   Protect, modify, deprotect (PMD): A strategy for creating vaccines to elicit antibodies targeting a specific epitope.
   Proc Natl Acad Sci U S A. 2019 Apr 26. pii: 1822062116.
   PubMed     Text format     Abstract available
   
   
   March 2019
4. STEFANETTI G, Okan N, Fink A, Gardner E, et al
   Glycoconjugate vaccine using a genetically modified O antigen induces protective antibodies to Francisella tularensis.
   Proc Natl Acad Sci U S A. 2019 Mar 14. pii: 1900144116.
   PubMed     Text format     Abstract available
   
   
   February 2019
5. NEIDEL S, Ren H, Torres AA, Smith GL, et al
   NF-kappaB activation is a turn on for vaccinia virus phosphoprotein A49 to turn off NF-kappaB activation.
   Proc Natl Acad Sci U S A. 2019 Feb 28. pii: 1813504116.
   PubMed     Text format     Abstract available
   
   
   
6. VANARSDALL AL, Chin AL, Liu J, Jardetzky TS, et al
   HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission.
   Proc Natl Acad Sci U S A. 2019;116:3728-3733.
   PubMed     Text format     Abstract available
   
   
   
7. TSENG YC, Wu CY, Liu ML, Chen TH, et al
   Egg-based influenza split virus vaccine with monoglycosylation induces cross-strain protection against influenza virus infections.
   Proc Natl Acad Sci U S A. 2019 Feb 19. pii: 1819197116.
   PubMed     Text format     Abstract available
   
   
   January 2019
8. MARTINS MA, Bischof GF, Shin YC, Lauer WA, et al
   Vaccine protection against SIVmac239 acquisition.
   Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 1814584116.
   PubMed     Text format     Abstract available
   
   
   December 2018
9. RAPPUOLI R, De Gregorio E, Costantino P
   On the mechanisms of conjugate vaccines.
   Proc Natl Acad Sci U S A. 2018 Dec 21. pii: 1819612116.
   PubMed     Text format    
   
   
   
10. BLOOM DE, Black S, Salisbury D, Rappuoli R, et al
    Antimicrobial resistance and the role of vaccines.
    Proc Natl Acad Sci U S A. 2018;115:12868-12871.
    PubMed     Text format    
    
    
    
11. SEVILLA JP, Bloom DE, Cadarette D, Jit M, et al
    Toward economic evaluation of the value of vaccines and other health technologies in addressing AMR.
    Proc Natl Acad Sci U S A. 2018;115:12911-12919.
    PubMed     Text format     Abstract available
    
    
    
12. KENNEDY DA, Read AF
    Why the evolution of vaccine resistance is less of a concern than the evolution of drug resistance.
    Proc Natl Acad Sci U S A. 2018;115:12878-12886.
    PubMed     Text format     Abstract available
    
    
    
13. KLUGMAN KP, Black S
    Impact of existing vaccines in reducing antibiotic resistance: Primary and secondary effects.
    Proc Natl Acad Sci U S A. 2018;115:12896-12901.
    PubMed     Text format     Abstract available
    
    
    
14. TEDIJANTO C, Olesen SW, Grad YH, Lipsitch M, et al
    Estimating the proportion of bystander selection for antibiotic resistance among potentially pathogenic bacterial flora.
    Proc Natl Acad Sci U S A. 2018;115:E11988-E11995.
    PubMed     Text format     Abstract available
    
    
    
15. BAKER SJ, Payne DJ, Rappuoli R, De Gregorio E, et al
    Technologies to address antimicrobial resistance.
    Proc Natl Acad Sci U S A. 2018;115:12887-12895.
    PubMed     Text format     Abstract available
    
    
    
16. KAPLONEK P, Khan N, Reppe K, Schumann B, et al
    Improving vaccines against Streptococcus pneumoniae using synthetic glycans.
    Proc Natl Acad Sci U S A. 2018 Dec 7. pii: 1811862115.
    PubMed     Text format     Abstract available
    
    
    
17. SUN X, Stefanetti G, Berti F, Kasper DL, et al
    Polysaccharide structure dictates mechanism of adaptive immune response to glycoconjugate vaccines.
    Proc Natl Acad Sci U S A. 2018 Dec 3. pii: 1816401115.
    PubMed     Text format     Abstract available
    
    
    November 2018
18. POGORELYY MV, Minervina AA, Touzel MP, Sycheva AL, et al
    Precise tracking of vaccine-responding T cell clones reveals convergent and personalized response in identical twins.
    Proc Natl Acad Sci U S A. 2018 Nov 20. pii: 1809642115.
    PubMed     Text format     Abstract available
    
    
    
19. FINK AL, Engle K, Ursin RL, Tang WY, et al
    Biological sex affects vaccine efficacy and protection against influenza in mice.
    Proc Natl Acad Sci U S A. 2018 Nov 19. pii: 1805268115.
    PubMed     Text format     Abstract available
    
    
    
20. STEWART-JONES GBE, Chuang GY, Xu K, Zhou T, et al
    Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1-4.
    Proc Natl Acad Sci U S A. 2018 Nov 12. pii: 1811980115.
    PubMed     Text format     Abstract available
    
    
    September 2018
21. MICOLI F, Rondini S, Alfini R, Lanzilao L, et al
    Comparative immunogenicity and efficacy of equivalent outer membrane vesicle and glycoconjugate vaccines against nontyphoidal Salmonella.
    Proc Natl Acad Sci U S A. 2018 Sep 27. pii: 1807655115.
    PubMed     Text format     Abstract available
    
    
    
22. CROFTS AA, Giovanetti SM, Rubin EJ, Poly FM, et al
    Enterotoxigenic E. coli virulence gene regulation in human infections.
    Proc Natl Acad Sci U S A. 2018;115:E8968-E8976.
    PubMed     Text format     Abstract available
    
    
    
23. BOTTERMANN M, Foss S, van Tienen LM, Vaysburd M, et al
    TRIM21 mediates antibody inhibition of adenovirus-based gene delivery and vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 12. pii: 1806314115.
    PubMed     Text format     Abstract available
    
    
    
24. HAABETH OAW, Blake TR, McKinlay CJ, Waymouth RM, et al
    mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice.
    Proc Natl Acad Sci U S A. 2018 Sep 10. pii: 1810002115.
    PubMed     Text format     Abstract available
    
    
    
25. PARKS RJ, Gussoni E
    Building immune tolerance through DNA vaccination.
    Proc Natl Acad Sci U S A. 2018 Sep 6. pii: 1813461115.
    PubMed     Text format    
    
    
    August 2018
26. JURASKA M, Magaret CA, Shao J, Carpp LN, et al
    Viral genetic diversity and protective efficacy of a tetravalent dengue vaccine in two phase 3 trials.
    Proc Natl Acad Sci U S A. 2018 Aug 20. pii: 1714250115.
    PubMed     Text format     Abstract available
    
    
    July 2018
27. DENG L, Chang TZ, Wang Y, Li S, et al
    Heterosubtypic influenza protection elicited by double-layered polypeptide nanoparticles in mice.
    Proc Natl Acad Sci U S A. 2018 Jul 31. pii: 1805713115.
    PubMed     Text format     Abstract available
    
    
    
28. LI W, Zhang X, Yang Y, Yin Q, et al
    Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary Haemophilus influenzae infection.
    Proc Natl Acad Sci U S A. 2018;115:E7149-E7157.
    PubMed     Text format     Abstract available
    
    
    
29. 
    Retraction for Ganesh et al., Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1806429115.
    PubMed     Text format    
    
    
    June 2018
30. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Text format     Abstract available
    
    
    
31. SCHLEISS MR
    Recombinant cytomegalovirus glycoprotein B vaccine: Rethinking the immunological basis of protection.
    Proc Natl Acad Sci U S A. 2018 Jun 6. pii: 1806420115.
    PubMed     Text format    
    
    
    May 2018
32. BRYNILDSRUD OB, Eldholm V, Bohlin J, Uadiale K, et al
    Acquisition of virulence genes by a carrier strain gave rise to the ongoing epidemics of meningococcal disease in West Africa.
    Proc Natl Acad Sci U S A. 2018;115:5510-5515.
    PubMed     Text format     Abstract available
    
    
    
33. TZENG SY, McHugh KJ, Behrens AM, Rose S, et al
    Stabilized single-injection inactivated polio vaccine elicits a strong neutralizing immune response.
    Proc Natl Acad Sci U S A. 2018 May 21. pii: 1720970115.
    PubMed     Text format     Abstract available
    
    
    April 2018
34. SAH P, Medlock J, Fitzpatrick MC, Singer BH, et al
    Optimizing the impact of low-efficacy influenza vaccines.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1802479115.
    PubMed     Text format     Abstract available
    
    
    
35. NELSON CS, Huffman T, Jenks JA, Cisneros de la Rosa E, et al
    HCMV glycoprotein B subunit vaccine efficacy mediated by nonneutralizing antibody effector functions.
    Proc Natl Acad Sci U S A. 2018 Apr 30. pii: 1800177115.
    PubMed     Text format     Abstract available
    
    
    
36. BARANIAK I, Kropff B, Ambrose L, McIntosh M, et al
    Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies.
    Proc Natl Acad Sci U S A. 2018 Apr 23. pii: 1800224115.
    PubMed     Text format     Abstract available
    
    
    
37. PETTIGREW MM, Ahearn CP, Gent JF, Kong Y, et al
    Haemophilus influenzae genome evolution during persistence in the human airways in chronic obstructive pulmonary disease.
    Proc Natl Acad Sci U S A. 2018;115:E3256-E3265.
    PubMed     Text format     Abstract available
    
    
    
38. STEVENSON TC, Cywes-Bentley C, Moeller TD, Weyant KB, et al
    Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies.
    Proc Natl Acad Sci U S A. 2018;115:E3106-E3115.
    PubMed     Text format     Abstract available
    
    
    March 2018
39. OBOLSKI U, Lourenco J, Thompson C, Thompson R, et al
    Vaccination can drive an increase in frequencies of antibiotic resistance among nonvaccine serotypes of Streptococcus pneumoniae.
    Proc Natl Acad Sci U S A. 2018 Mar 6. pii: 1718712115.
    PubMed     Text format     Abstract available
    
    
    January 2018
40. VERMA AA, Jimenez MP, Tangermann RH, Subramanian SV, et al
    Insecurity, polio vaccination rates, and polio incidence in northwest Pakistan.
    Proc Natl Acad Sci U S A. 2018 Jan 29. pii: 1711923115.
    PubMed     Text format     Abstract available
    
    
    December 2017
41. RAYMOND DD, Bajic G, Ferdman J, Suphaphiphat P, et al
    Conserved epitope on influenza-virus hemagglutinin head defined by a vaccine-induced antibody.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1715471115.
    PubMed     Text format     Abstract available
    
    
    
42. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Text format     Abstract available
    
    
    
43. PANANOS AD, Bury TM, Wang C, Schonfeld J, et al
    Critical dynamics in population vaccinating behavior.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1704093114.
    PubMed     Text format     Abstract available
    
    
    
44. WEISBERG AS, Maruri-Avidal L, Bisht H, Hansen BT, et al
    Enigmatic origin of the poxvirus membrane from the endoplasmic reticulum shown by 3D imaging of vaccinia virus assembly mutants.
    Proc Natl Acad Sci U S A. 2017 Dec 4. pii: 1716255114.
    PubMed     Text format     Abstract available
    
    
    November 2017
45. ZOST SJ, Parkhouse K, Gumina ME, Kim K, et al
    Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains.
    Proc Natl Acad Sci U S A. 2017 Nov 6. pii: 201712377.
    PubMed     Text format     Abstract available
    
    
    October 2017
46. KOEHLER H, Cotsmire S, Langland J, Kibler KV, et al
    Inhibition of DAI-dependent necroptosis by the Z-DNA binding domain of the vaccinia virus innate immune evasion protein, E3.
    Proc Natl Acad Sci U S A. 2017;114:11506-11511.
    PubMed     Text format     Abstract available
    
    
    
47. BUSTAMANTE LY, Powell GT, Lin YC, Macklin MD, et al
    Synergistic malaria vaccine combinations identified by systematic antigen screening.
    Proc Natl Acad Sci U S A. 2017 Oct 23. pii: 201702944.
    PubMed     Text format     Abstract available
    
    
    
48. LISBOA MP, Khan N, Martin C, Xu FF, et al
    Semisynthetic glycoconjugate vaccine candidate against Streptococcus pneumoniae serotype 5.
    Proc Natl Acad Sci U S A. 2017 Oct 2. pii: 201706875.
    PubMed     Text format     Abstract available
    
    
    May 2017
49. PIZZOLLA A, Wang Z, Groom JR, Kedzierska K, et al
    Nasal-associated lymphoid tissues (NALTs) support the recall but not priming of influenza virus-specific cytotoxic T cells.
    Proc Natl Acad Sci U S A. 2017 May 1. pii: 201620194.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Vaccines is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: